Conba Group’s subsidiary Zhejiang Conba Pharmaceutical has completed the sale of 57.3% stake in a pharmaceutical company.
"Zhejiang Conba has received a consideration of ¥345.1m ($50.27m) from the stake sale."
Zhejiang Conba has received a consideration of ¥345.1m ($50.27m) from the stake sale.
Go deeper with GlobalData
Based in China, Zhejiang Conba Pharmaceutical sells medicines and chemical products.
Chabiotech subsidiary CHA Healthcare has reached an agreement to acquire 8.8% stake in Singapore Medical Group.
The stake represents 30 million shares of the target company and costs KRW12.07bn ($10.23m) for the acquirer company.
